Effect of rpoB Mutations Conferring Rifampin Resistance on Fitness of Mycobacterium tuberculosis
Open Access
- 1 April 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (4) , 1289-1294
Abstract
Rifampin is a major drug used in the treatment of tuberculosis infections, and increasing rifampin resistance represents a worldwide clinical problem. Resistance to rifampin is caused by mutations in the rpoB gene, encoding the β-subunit of RNA polymerase. We examined the effect of three different rpoB mutations on the fitness of Mycobacterium tuberculosis . Rifampin-resistant mutants were isolated from a virulent clinical isolate of M. tuberculosis (strain Harlingen) in vitro at a mutation frequency of 2.3 × 10 −8 . Mutations in the rpoB gene were identified, and the growth rates of three defined mutants were measured by competition with the susceptible parent strain in laboratory medium and by single cultures in a macrophage cell line and in laboratory medium. All of the mutants showed a decreased growth rate in the three assays. The relative fitness of the mutants varied between 0.29 and 0.96 (that of the susceptible strain was set to 1.0) depending on the specific mutant and assay system. Unexpectedly, the relative fitness ranking of the mutants differed between the different assays. In conclusion, rifampin resistance is associated with a cost that is conditional.Keywords
This publication has 32 references indexed in Scilit:
- Drug-Susceptible Mycobacterium tuberculosis Beijing Genotype Does Not Develop Mutation-Conferred Resistance to Rifampin at an Elevated RateJournal of Clinical Microbiology, 2003
- Biological Cost of Rifampin Resistance from the Perspective of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2002
- Effect of katG Mutations on the Virulence of Mycobacterium tuberculosis and the Implication for Transmission in HumansInfection and Immunity, 2002
- Evolutionary Barriers to Quinolone Resistance in Streptococcus pneumoniaeMicrobial Drug Resistance, 2002
- Prediction of Drug Resistance in M. tuberculosis: Molecular Mechanisms, Tools, and ApplicationsIUBMB Life, 2002
- rpoB Genotypes of Mycobacterium tuberculosis Beijing Family Isolates from East Asian CountriesJournal of Clinical Microbiology, 2002
- Effects of Environment on Compensatory Mutations to Ameliorate Costs of Antibiotic ResistanceScience, 2000
- Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis Science, 1996
- Reducing antibiotic resistanceNature, 1996
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993